Showing results (381-390 of 476) with videos related to
Sort By:
Pageof 48
The Journal of Biological Chemistry|September 26, 2003
The hsp90 cochaperone p23 is the limiting component of the multiprotein hsp90/hsp70-based chaperone system in vivo where it acts to stabilize the client protein: hsp90 complexYoshihiro Morishima, Kimon C Kanelakis, Patrick J M Murphy, et al.Cancer|June 15, 1997
Brain metastases in children with melanomaC Rodriguez-Galindo, A S Pappo, S C Kaste, et al.Journal of Pediatric Surgery|September 22, 2000
Childhood carcinoid tumors: the St Jude Children's Research Hospital experienceS L Spunt, C B Pratt, B N Rao, et al.Cancer|January 15, 1994
Paratesticular rhabdomyosarcoma: delayed effects of multimodality therapy and implications for current managementL L Hughes, M J Baruzzi, R C Ribeiro, et al.Journal of Pediatric Surgery|December 1, 1983
Limb salvage procedures for children with osteosarcoma: an alternative to amputationB N Rao, J E Champion, C B Pratt, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Subsequent malignancies in children and adolescents after treatment for Hodgkin's diseaseO Beaty, M M Hudson, C Greenwald, et al.Molecular Pharmacology|June 27, 2018
Chaperone Activity and Dimerization Properties of Hsp90α and Hsp90β in Glucocorticoid Receptor Activation by the Multiprotein Hsp90/Hsp70-Dependent Chaperone MachineryYoshihiro Morishima, Ranjit K Mehta, Miyako Yoshimura, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemiasM H Woo, M V Relling, D S Sonnichsen, et al.Journal of Pediatric Hematology/Oncology|April 25, 2002
Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposideCarlos Rodríguez-Galindo, Najat C Daw, Sue C Kaste, et al.Cancer|November 1, 1994
Phase II study of 5-fluorouracil/leucovorin for pediatric patients with malignant solid tumorsC B Pratt, W H Meyer, N Howlett, et al.Pageof 48